Jeff Yass’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-68,540
Closed -$28.8K 13836
2022
Q4
$28.8K Buy
+68,540
New +$69K ﹤0.01% 11635
2022
Q3
Sell
-67,484
Closed -$119K 14415
2022
Q2
$196K Buy
67,484
+33,490
+99% +$141K ﹤0.01% 10666
2022
Q1
$256K Buy
33,994
+3,881
+13% +$32.1K ﹤0.01% 10664
2021
Q4
$421K Buy
30,113
+5,942
+25% +$117K ﹤0.01% 9630
2021
Q3
$625K Buy
24,171
+5,810
+32% +$184K ﹤0.01% 8811
2021
Q2
$840K Buy
+18,361
New +$868K ﹤0.01% 8242

Other funds holding AMTI

Jeff Yass's AMTI Position: Q1 2023 in Review

Jeff Yass sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q1 2023, closing a stake of 68,540 shares — an estimated $28.8K sold.

Jeff Yass first reported a position in AMTI in Q2 2021 and held it in 6 quarters. The position peaked at $840K in Q2 2021. 35 funds tracked by Wall St. Rank hold AMTI as of Q1 2023.

  • Jeff Yass reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Jeff Yass sold 68,540 Applied Molecular Transport Inc. Common Stock shares in Q1 2023, an estimated $28.8K.
  • Jeff Yass first reported a position in Applied Molecular Transport Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • Jeff Yass's Applied Molecular Transport Inc. Common Stock position peaked at $840K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.